Recommend AZO Urinary Pain Relief®
AZO Urinary Pain Relief® contains phenazopyridine hydrochloride in either 95 mg or 97.5 mg tablets for fast, targeted, over-the-counter relief. When UTIs strike your patients, AZO Urinary Pain Relief® is a nonprescription option that can help ease suffering while they wait to see you and while waiting for their antibiotics to take effect.
Phenazopyridine HCl has been proven effective for the symptomatic relief of the pain, burning, urgency and frequency typically experienced with UTIs.1 Phenazopyridine HCl is excreted in the urine and exerts a topical analgesic effect on the mucosa of the urinary tract.2,3
Efficacy
The benefits of AZO Urinary Pain Relief® and AZO Urinary Pain Relief® Maximum Strength may be experienced as soon as 20 minutes and within 1 hour, the time in which phenazopyridine hydrochloride reaches the bladder as indicated by a change in urine color.4
Safety
In the U.S., phenazopyridine hydrochloride has been widely prescribed for symptomatic relief of urinary tract infections since 1914.1
Directions For Use
Adults and children 12 years and older: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Patients should not use for more than 2 days (12 tablets) without consulting a doctor.
AZO Urinary Pain Relief® Maximum Strength
AZO Urinary Pain Relief® Maximum Strength
Active Ingredients:
- Phenazopyridine hydrochloride 97.5mg..........Urinary tract analgesic
AZO Urinary Pain Relief®
AZO Urinary Pain Relief®
Active Ingredients:
- Phenazopyridine hydrochloride 95mg..........Urinary tract analgesic
2Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman AG, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996, p 1070.
3Warner Chilcott – Pyridium Rx ( http://www.wcrx.com/pdfs/pi/pyridium_pi_cpc.pdf).
4Hui, JYC, Harvey M, Johnston SL. Confirmation of ureteric patency during cystoscopy using phenazopyridine HCl: a low-cost approach. Journal of Obstetrics and Gynaecology Canada 31.9 (2009) p 845-849.
